Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCDC61 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
mRNA | WISP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CDK5RAP1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | DCAF17 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | NTMT1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | MFNG | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
mRNA | IARS2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | DDB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | FAM53B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | NDUFAB1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |